The human urinary bladder is an organ in which there is clear epidemiological evidence showing that exposure to environmental chemicals plays a significant etiololgical role in carcinogenesis. For this reason, the development of an in vitro model system to study chemical transformation of human urothelial cells has particular significance and relevance. The primary objective of this project is to perform quantitative studies of cytotoxicity and transformation using cultured normal human transitional epithelial cells. This project is possible because we have developed methods for routinely culturing normal human transitional cells and for quantitatively determining cytotoxicity in these cultures. In addition, we have identified morphological markers in vitro for cultured human transitional carcinoma cells which are potentially useful for transformation assays in vitro. The industrial chemicals 2-napthylamine, 4-aminobiphenyl, and 2-nitrobiphenyl (all human bladder carcinogens requiring metabolic activation), as well as the direct acting carcinogen, N-methyl-N-nitrosourea, will be used in these experiments. Markers used to score transformation will include morphological alterations, growth in soft agar, formation of permanent cell lines, and tumorigenicity in nude mice. The ability of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), and the dietary supplement, sodium saccharin to act as promoters in two stage carcinogenesis of human urothelial cells will be evaluated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA029525-06
Application #
3168734
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1984-02-01
Project End
1987-01-31
Budget Start
1986-02-01
Budget End
1987-01-31
Support Year
6
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Sarkar, S; Julicher, K P; Burger, M S et al. (2000) Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers. Cancer Res 60:3862-71
Cuthill, S; Agarwal, P; Sarkar, S et al. (1999) Dominant genetic alterations in immortalization: role for 20q gain. Genes Chromosomes Cancer 26:304-11
Vieten, L; Belair, C D; Savelieva, L et al. (1998) Minimal deletion of 3p13-->14.2 associated with immortalization of human uroepithelial cells. Genes Chromosomes Cancer 21:39-48
Yeager, T R; Reznikoff, C A (1998) Methotrexate resistance in human uroepithelial cells with p53 alterations. J Urol 159:581-5
Savelieva, E; Belair, C D; Newton, M A et al. (1997) 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 14:551-60
Belair, C D; Yeager, T R; Lopez, P M et al. (1997) Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci U S A 94:13677-82
Reznikoff, C A; Belair, C D; Yeager, T R et al. (1996) A molecular genetic model of human bladder cancer pathogenesis. Semin Oncol 23:571-84
Reznikoff, C A; Yeager, T R; Belair, C D et al. (1996) Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res 56:2886-90
Reznikoff, C A; Belair, C; Savelieva, E et al. (1994) Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. Genes Dev 8:2227-40
Reznikoff, C A; Kao, C; Messing, E M et al. (1993) A molecular genetic model of human bladder carcinogenesis. Semin Cancer Biol 4:143-52

Showing the most recent 10 out of 21 publications